FYSIOTERAPEUT LONE ELKJÆR HALLUM ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  3.0% 4.0% 3.4% 1.8% 2.2%  
Credit score (0-100)  59 50 52 71 60  
Credit rating  BBB BBB BBB A BBB  
Credit limit (kDKK)  0.0 0.0 0.0 1.2 0.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  451 -16.0 -17.0 -8.0 -9.8  
EBITDA  451 -16.0 -17.0 -8.0 -9.8  
EBIT  451 -16.0 -17.0 -8.0 -9.8  
Pre-tax profit (PTP)  455.0 -10.0 -430.0 -1.0 0.5  
Net earnings  455.0 -10.0 -430.0 -1.0 0.5  
Pre-tax profit without non-rec. items  455 -10.0 -430 -1.0 0.5  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  789 779 2,708 2,706 2,707  
Interest-bearing liabilities  0.0 4.0 0.0 1.0 0.0  
Balance sheet total (assets)  815 804 2,735 2,735 2,736  

Net Debt  -13.0 -6.0 -3.0 -2.0 0.0  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  451 -16.0 -17.0 -8.0 -9.8  
Gross profit growth  -3.4% 0.0% -6.3% 52.9% -22.8%  
Employees  0 0 0 0 0  
Employee growth %  -100.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  815 804 2,735 2,735 2,736  
Balance sheet change%  81.5% -1.3% 240.2% 0.0% 0.0%  
Added value  451.0 -16.0 -17.0 -8.0 -9.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  72.0% -1.2% 23.2% -0.0% 0.1%  
ROI %  81.0% -1.3% -24.6% -0.0% 0.1%  
ROE %  81.0% -1.3% -24.7% -0.0% 0.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  96.8% 96.9% 99.0% 98.9% 98.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -2.9% 37.5% 17.6% 25.0% 0.0%  
Gearing %  0.0% 0.5% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 243.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  9.8 9.8 8.8 8.2 8.2  
Current Ratio  9.8 9.8 8.8 8.2 8.2  
Cash and cash equivalent  13.0 10.0 3.0 3.0 0.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  230.0 220.0 210.0 208.0 209.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0